{"gene":"SEC23B","run_date":"2026-04-28T20:42:07","timeline":{"discoveries":[{"year":2009,"finding":"SEC23B is a component of the COPII coat protein complex involved in ER-to-Golgi vesicular transport, and loss-of-function mutations in SEC23B cause congenital dyserythropoietic anemia type II (CDAII). shRNA-mediated suppression of SEC23B expression recapitulates the cytokinesis defect seen in CDAII, and knockdown of zebrafish sec23b leads to aberrant erythrocyte development, demonstrating SEC23B selectivity in erythroid differentiation.","method":"shRNA knockdown in human cells, zebrafish sec23b morpholino knockdown, SEC23B gene sequencing in CDAII patients","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (patient genetics, shRNA knockdown phenotype, zebrafish in vivo knockdown), replicated across two independent studies in same year","pmids":["19561605","19621418"],"is_preprint":false},{"year":2009,"finding":"SEC23B encodes a COPII coat component that functions in ER-to-Golgi trafficking; its loss disturbs endoplasmic reticulum-to-Golgi trafficking, affecting glycosylation pathways and accounting for the hypoglycosylation of red blood cell membrane proteins observed in CDAII.","method":"Proteomic-genomic approach matching cytoplasmic proteome of human RBCs with CDAN2 chromosomal locus; SEC23B gene sequencing revealing 12 different mutations","journal":"Human mutation","confidence":"High","confidence_rationale":"Tier 2 — proteomic-genomic approach identifying SEC23B as causative gene, corroborated by independent replication","pmids":["19621418"],"is_preprint":false},{"year":2012,"finding":"SEC23B is required for ER exit of highly abundant cargo in professional secretory tissues. SEC23B-deficient mice die perinatally with degeneration of pancreatic acinar cells and salivary glands but not liver; loss of SEC23B causes ER distension, accumulation of proteins in the ER lumen, and activation of the proapoptotic unfolded protein response pathway, demonstrating tissue-specific dependence on SEC23B for ER export.","method":"Germline SEC23B knockout mouse; electron microscopy of pancreatic acini; UPR/apoptosis pathway analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — clean KO mouse with defined cellular and molecular phenotypes (ER distension, UPR activation, apoptosis), multiple orthogonal readouts","pmids":["22745161"],"is_preprint":false},{"year":2014,"finding":"SEC23B deficiency restricted to the hematopoietic compartment in mice does not produce anemia or other CDAII features, and SEC23B-deficient hematopoietic stem cells show no disadvantage in competitive repopulation assays, indicating that the erythroid-specific requirement for SEC23B in humans is not recapitulated in mice, possibly due to species-specific shifts in SEC23 paralog expression.","method":"Conditional hematopoietic-specific SEC23B knockout mice; bone marrow transplantation and competitive repopulation assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — clean conditional KO with competitive repopulation assay providing rigorous functional readout","pmids":["25071156"],"is_preprint":false},{"year":2016,"finding":"Pancreatic SEC23B deficiency alone is sufficient to explain the perinatal lethality of germline SEC23B-deficient mice, whereas pancreatic SEC23A deficiency does not cause lethality or pancreatic pathology, demonstrating SEC23B-specific (not SEC23A) requirement for murine pancreatic development.","method":"Pancreas-specific conditional SEC23B knockout mice; pancreas-specific SEC23A knockout mice; BAC transgene rescue experiments; immunohistochemistry","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 — multiple genetic models (tissue-specific KO, transgenic rescue) with defined molecular and cellular phenotypes","pmids":["27297878"],"is_preprint":false},{"year":2017,"finding":"SEC23B is required for normal function of pancreatic acinar cells in adult mice; acinar cell-specific Sec23b deletion results in decreased zymogen granules, ER alterations (vesicular ER to expanded cisternae with intracisternal granules), induction of ER stress, and increased apoptosis leading to pancreatic cell loss.","method":"Tamoxifen-inducible, pancreatic acinar cell-specific Sec23b deletion in adult mice; electron microscopy; ER stress and apoptosis markers","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — inducible tissue-specific KO in adult animals with ultrastructural, molecular, and cellular phenotype readouts","pmids":["28539403"],"is_preprint":false},{"year":2018,"finding":"SEC23A and SEC23B have indistinguishable intracellular protein interactomes in human cells, both complement yeast Sec23, and a Sec23a coding sequence knocked into the murine Sec23b locus completely rescues the lethal SEC23B-deficient pancreatic phenotype. The distinct phenotypes of SEC23A/B deficiency across and within species are explained by evolutionary shifts in their transcription programs rather than unique protein functions.","method":"Mass spectrometry interactome analysis; yeast complementation assay; zebrafish transgenic rescue; mouse knockin (Sec23a coding sequence into Sec23b locus)","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (MS interactome, yeast complementation, in vivo knockin rescue) in a single study","pmids":["30065114"],"is_preprint":false},{"year":2018,"finding":"The F-box protein FBXW5 targets SEC23B for proteasomal degradation, limiting autophagic flux in nutrient-replete conditions. In response to starvation, ULK1 phosphorylates SEC23B on Serine 186, preventing FBXW5 interaction and SEC23B degradation. Phosphorylated, stabilized SEC23B associates selectively with SEC24A and SEC24B (not SEC24C/D) and relocalizes to the ER-Golgi intermediate compartment to promote autophagic flux.","method":"Co-immunoprecipitation; mass spectrometry; in vitro kinase assay; site-directed mutagenesis (S186); subcellular fractionation and live imaging; proteasome inhibitor experiments; autophagy flux assays","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1-2 — reconstituted kinase assay, mutagenesis, reciprocal Co-IP, and functional flux assays in a single study with multiple orthogonal methods","pmids":["30596474"],"is_preprint":false},{"year":2018,"finding":"Cancer-associated mutant SEC23B localizes to nucleoli independent of other COPII proteins, without compromising secretory function. Mutant SEC23B binds to UBF transcription factor with increased UBF binding at the ribosomal DNA promoter, and mutant cells have increased ribosomal protein and translation-related gene expression and enhanced translational capacity in the presence of ER stress, indicating a non-canonical COPII-independent function in ribosome biogenesis.","method":"Immunofluorescence/confocal microscopy (nucleolar localization); co-immunoprecipitation (SEC23B-UBF interaction); ChIP (UBF at rDNA promoter); gene expression microarray; translation assays","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP, ChIP, and localization studies from a single lab with multiple methods but limited independent replication","pmids":["29893852"],"is_preprint":false},{"year":2020,"finding":"SEC23B selectively interacts with SEC24A (not other SEC24 paralogs) to form a COPII complex that the hepatitis B virus envelope exploits for ER export. The interaction involves the N-terminal half of SEC24A and a di-arginine motif of the HBV S domain, and HBV replication upregulates SEC23B and SEC24A transcription.","method":"Yeast-based proteomics; siRNA silencing of SEC23 and SEC24 paralogs; co-immunoprecipitation; secretion assays in HBV-expressing liver cells","journal":"Cellular microbiology","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP and paralog-specific knockdown with functional secretion readout from a single study","pmids":["32017353"],"is_preprint":false},{"year":2020,"finding":"SEC23B mutations impair membrane localization of adhesion proteins EPCAM and CD9, attenuating cell adhesion and promoting invasiveness of colorectal cancer cells. Specific SEC23B mutations (premature stop C649T, or transport-impairing missense C1467G, T488C+G791A+G2153A) inhibit protein transport activity and reduce membrane EPCAM and CD9 levels.","method":"Whole-exome sequencing; SEC23B deletion/mutation cell lines; flow cytometry for membrane proteins; cell adhesion and invasion assays in vitro and in vivo (mouse)","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2-3 — deletion/mutation functional assays with defined cargo (EPCAM, CD9) and invasion phenotype from a single study","pmids":["32123160"],"is_preprint":false},{"year":2021,"finding":"Wild-type SEC23B localizes to the nucleus in addition to the ER/Golgi interface, and to nucleoli under proteasome inhibition, independent of COPII. Mass spectrometry revealed that wild-type SEC23B interacts with nuclear proteins and with proteins in the ER stress, protein ubiquitination, and EIF2 signaling pathways. SEC23B-UBA52 (RPL40) interaction is validated in a genotype-specific manner. SEC23B levels increase in response to ER stress.","method":"Immunofluorescence/confocal microscopy; subcellular fractionation; mass spectrometry proteomics; co-immunoprecipitation (SEC23B-UBA52); patient-derived lymphoblastoid cell lines; ER stress induction experiments","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2-3 — unbiased MS proteomics validated by Co-IP, with localization studies; single lab, multiple methods","pmids":["33753724"],"is_preprint":false},{"year":2021,"finding":"Expression of the full SEC23A protein from endogenous Sec23b regulatory elements completely rescues the SEC23B-deficient mouse phenotype. Erythroid-specific deletion of all four Sec23 alleles (both Sec23a and Sec23b) causes mid-embryonic lethality with CDAII features, and deletion of three alleles produces milder erythroid defects. In human SEC23B-deficient HUDEP-2 cells, CDAII features upon differentiation are rescued by increased SEC23A expression.","method":"Knockin mouse (SEC23A from Sec23b locus); erythroid-specific conditional double KO mice; SEC23B-deficient HUDEP-2 human erythroid cell line; SEC23A overexpression rescue","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 1-2 — multiple genetic in vivo models plus human cell line rescue; strong mechanistic conclusions with orthogonal approaches","pmids":["34818036"],"is_preprint":false},{"year":2021,"finding":"The common human E109K SEC23B mutation leads to decreased SEC23B protein levels and protein mislocalization. In Sec23b hemizygous (Sec23bki/ko) mice, this results in exocrine pancreatic insufficiency with ER stress and apoptosis, chronic pancreatitis, mild anemia, and severe growth restriction with growth hormone insensitivity. Growth restriction is not associated with hepatocyte-specific Sec23b deletion, implicating a non-liver origin (pancreatic inflammation).","method":"Knockin mouse (E109K); conditional hepatocyte-specific Sec23b KO; protein localization studies; ER stress and apoptosis markers; GH axis measurements","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — knockin and tissue-specific KO models with defined molecular and endocrine phenotypes, multiple orthogonal readouts","pmids":["34954140"],"is_preprint":false},{"year":2022,"finding":"SEC23B loss-of-function in human hepatic cells (HuH7 and HepG2) impairs glycosylation of membrane proteins involved in the BMP/SMAD pathway, reduces BMP6 sensing, and suppresses hepcidin expression, contributing to iron overload in CDAII. SEC23A overexpression rescues hepcidin suppression, demonstrating functional overlap between SEC23 paralogs in human hepatic cells.","method":"Stable SEC23B shRNA silencing in HuH7 and HepG2 cell lines; BMP/SMAD pathway analysis; hepcidin assay; glycosylation studies; SEC23A overexpression rescue","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2-3 — stable knockdown in two cell lines with pathway analysis and rescue, but single lab","pmids":["35163229"],"is_preprint":false},{"year":2015,"finding":"A germline heterozygous SEC23B variant (p.Val594Gly) results in ER-stress-mediated cell colony formation, survival, growth, and invasion in a normal thyroid cell line, distinct from the recessive loss-of-function mechanism causing CDAII. This indicates SEC23B has a role in ER stress response pathways relevant to cancer predisposition.","method":"Functional characterization of p.Val594Gly variant in normal thyroid cell line (colony formation, growth, invasion assays); whole-exome sequencing of Cowden syndrome family","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 3 — functional cell-based assays in a single study establishing gain-of-function ER stress mechanism for cancer-associated variant","pmids":["26522472"],"is_preprint":false},{"year":2013,"finding":"Hypomorphic SEC23B mutations that reduce gene expression are not associated with severe CDAII clinical presentation; a compensation mechanism mediated by SEC23A is proposed to justify less severe phenotypes when SEC23B expression is reduced but not absent.","method":"Molecular analysis of five novel mutations; SEC23B mRNA and protein quantification in patient erythroid precursors; SEC23A expression analysis","journal":"Blood cells, molecules & diseases","confidence":"Low","confidence_rationale":"Tier 3 — patient molecular analysis with expression quantification; SEC23A compensation proposed but not directly tested by functional experiment","pmids":["23453696"],"is_preprint":false}],"current_model":"SEC23B is a core component of the COPII vesicle coat that functions as a GTPase-activating protein for SAR1 and mediates ER-to-Golgi transport of secretory proteins; its loss causes tissue-specific ER stress and UPR-mediated apoptosis in professional secretory tissues (pancreas, salivary gland) and, in humans, disrupts glycosylation of erythroid membrane proteins leading to CDAII; during starvation, ULK1 phosphorylates SEC23B at Ser186 to prevent FBXW5-mediated proteasomal degradation, stabilizing a SEC23B–SEC24A/B complex that relocalizes to the ERGIC to promote autophagosome biogenesis; additionally, SEC23B has non-canonical COPII-independent roles in the nucleus/nucleolus, interacting with UBF at rDNA promoters and with ER stress/EIF2 signaling pathway proteins, and its functional redundancy with SEC23A is determined by species- and tissue-specific differences in paralog expression rather than intrinsic biochemical differences between the two proteins."},"narrative":{"teleology":[{"year":2009,"claim":"Identification of SEC23B as the CDAII gene established that a specific COPII coat paralog is selectively required for normal erythropoiesis and proper glycosylation of red blood cell membrane proteins, answering which trafficking machinery component underlies this congenital anemia.","evidence":"Patient sequencing identifying SEC23B mutations, shRNA knockdown recapitulating cytokinesis defects, and zebrafish morpholino knockdown causing aberrant erythrocyte development","pmids":["19561605","19621418"],"confidence":"High","gaps":["Mechanism by which SEC23B loss specifically impairs erythroid glycosylation was not resolved","Whether SEC23A could compensate for SEC23B loss in erythroid cells was untested","Cargo selectivity of SEC23B versus SEC23A was unknown"]},{"year":2012,"claim":"The generation of SEC23B knockout mice revealed that SEC23B is essential for ER export in professional secretory tissues (pancreas, salivary gland) but not liver or erythroid cells in this species, establishing that tissue-specific secretory load determines dependence on SEC23B.","evidence":"Germline SEC23B knockout mouse with electron microscopy showing ER distension and UPR/apoptosis pathway activation in pancreatic acinar cells","pmids":["22745161"],"confidence":"High","gaps":["Why murine erythropoiesis was spared, unlike human CDAII, was unexplained","Whether the lethality mapped specifically to pancreatic loss of SEC23B was untested","The relative contributions of SEC23A expression levels versus intrinsic protein differences remained ambiguous"]},{"year":2014,"claim":"Hematopoietic-specific conditional knockout showed that murine blood formation does not require SEC23B, raising the hypothesis that species-specific paralog expression rather than unique protein functions explains the human-mouse phenotypic discrepancy.","evidence":"Conditional hematopoietic-specific SEC23B knockout mice with bone marrow transplantation and competitive repopulation assays","pmids":["25071156"],"confidence":"High","gaps":["Direct measurement of SEC23A versus SEC23B expression in murine versus human erythroid progenitors was not provided","Whether forced reduction of SEC23A in murine erythroid cells would recapitulate CDAII was untested"]},{"year":2016,"claim":"Tissue-specific knockouts demonstrated that pancreatic SEC23B deficiency alone accounts for perinatal lethality, while SEC23A loss in pancreas does not, pinpointing the organ and paralog responsible for the mouse lethal phenotype.","evidence":"Pancreas-specific conditional SEC23B and SEC23A knockout mice with BAC transgene rescue","pmids":["27297878"],"confidence":"High","gaps":["Whether the pancreatic phenotype reflects a unique cargo requirement or simply expression dominance of SEC23B was unresolved","Adult pancreatic consequences of SEC23B loss had not yet been examined"]},{"year":2017,"claim":"Inducible acinar-specific SEC23B deletion in adult mice confirmed that SEC23B is continuously required for zymogen granule biogenesis and ER homeostasis in the mature pancreas, not only during development.","evidence":"Tamoxifen-inducible acinar cell-specific Sec23b deletion in adult mice with electron microscopy and ER stress/apoptosis markers","pmids":["28539403"],"confidence":"High","gaps":["Identity of the specific cargo proteins whose trafficking depends on SEC23B in acinar cells was not determined","Whether SEC23A upregulation could partially compensate over longer time frames was unknown"]},{"year":2018,"claim":"Comprehensive interactome and genetic rescue experiments proved that SEC23A and SEC23B are biochemically interchangeable—SEC23A expressed from the SEC23B locus fully rescues the knockout—definitively attributing tissue-specific phenotypes to transcriptional regulation rather than unique protein activities.","evidence":"Mass spectrometry interactome comparison; yeast complementation; zebrafish transgenic rescue; mouse knockin of Sec23a coding sequence into Sec23b locus","pmids":["30065114"],"confidence":"High","gaps":["Cis-regulatory elements governing tissue-specific SEC23B transcription were not mapped","Whether subtle kinetic or affinity differences exist under specific stress conditions was not excluded"]},{"year":2018,"claim":"Discovery that ULK1 phosphorylates SEC23B at Ser186 to prevent FBXW5-mediated degradation established a non-canonical role for SEC23B in autophagosome biogenesis at the ERGIC, linking COPII coat components to the autophagy machinery.","evidence":"In vitro kinase assay, site-directed mutagenesis of S186, co-immunoprecipitation, subcellular fractionation, and autophagy flux assays","pmids":["30596474"],"confidence":"High","gaps":["How the phosphorylated SEC23B–SEC24A/B complex mechanistically promotes autophagosome membrane formation was not determined","Physiological significance of this pathway in vivo (animal models) was not tested","Whether SEC23A is similarly regulated by ULK1/FBXW5 was not addressed"]},{"year":2018,"claim":"The finding that cancer-associated mutant SEC23B localizes to nucleoli, binds UBF at rDNA promoters, and enhances translational capacity revealed a COPII-independent function in ribosome biogenesis.","evidence":"Confocal microscopy for nucleolar localization; co-immunoprecipitation for SEC23B–UBF interaction; ChIP at rDNA promoter; gene expression microarray and translation assays","pmids":["29893852"],"confidence":"Medium","gaps":["Whether wild-type SEC23B has the same nucleolar function or this is neomorphic was unclear","Not independently replicated at time of publication","Structural basis for SEC23B–UBF interaction was not determined"]},{"year":2021,"claim":"Demonstration that wild-type SEC23B also localizes to the nucleus and interacts with ER stress/EIF2 signaling and ubiquitination pathway proteins extended the non-canonical nuclear role beyond cancer mutants, establishing that nuclear SEC23B function is a normal feature of the protein.","evidence":"Subcellular fractionation, confocal microscopy, mass spectrometry proteomics, and co-immunoprecipitation in patient-derived lymphoblastoid cell lines","pmids":["33753724"],"confidence":"Medium","gaps":["Functional consequences of nuclear SEC23B interactions on ER stress signaling were not causally tested","Single-lab study awaiting independent confirmation","How SEC23B translocates to the nucleus (NLS, chaperone-mediated) is unknown"]},{"year":2021,"claim":"Genetic proof that SEC23A expressed from the SEC23B locus fully rescues all SEC23B-deficient phenotypes in mice, and that combined erythroid deletion of all four Sec23 alleles produces CDAII-like features, conclusively resolved the paralog redundancy question and demonstrated that total SEC23 dosage determines erythroid phenotype.","evidence":"Knockin mouse expressing SEC23A from Sec23b regulatory elements; erythroid-specific double conditional KO; SEC23A overexpression rescue in human HUDEP-2 cells","pmids":["34818036"],"confidence":"High","gaps":["Threshold of total SEC23 protein needed for normal erythropoiesis was not quantified","Whether gene therapy increasing SEC23A could treat CDAII patients was not tested"]},{"year":2021,"claim":"Modeling the common CDAII E109K mutation in mice revealed that reduced SEC23B protein levels and mislocalization cause exocrine pancreatic insufficiency with chronic pancreatitis and growth hormone insensitivity, connecting SEC23B hypomorphism to systemic endocrine consequences.","evidence":"E109K knockin mouse; hepatocyte-specific conditional Sec23b KO; protein localization, ER stress markers, and growth hormone axis measurements","pmids":["34954140"],"confidence":"High","gaps":["Mechanism of growth hormone insensitivity (pancreatic inflammation versus direct SEC23B effect) was not fully dissected","Whether these pancreatic/endocrine features occur in human CDAII patients is unknown"]},{"year":2022,"claim":"SEC23B loss in hepatic cells impairs glycosylation of BMP/SMAD pathway receptors and suppresses hepcidin expression, providing a molecular explanation for iron overload in CDAII beyond erythroid defects.","evidence":"Stable SEC23B shRNA silencing in HuH7 and HepG2 hepatic cell lines with BMP/SMAD pathway and hepcidin assays; SEC23A overexpression rescue","pmids":["35163229"],"confidence":"Medium","gaps":["In vivo validation of hepatic hepcidin suppression in SEC23B-deficient models was not performed","Contribution of hepatic versus erythroid dysfunction to CDAII iron overload was not quantified"]},{"year":null,"claim":"Key unresolved questions include the structural basis for SEC23B's nuclear import and nucleolar functions, the specific cargo repertoire that depends on SEC23B versus SEC23A in different tissues, the in vivo significance of the ULK1–SEC23B autophagy axis, and whether therapeutic SEC23A upregulation can rescue CDAII in patients.","evidence":"","pmids":[],"confidence":"Low","gaps":["No nuclear localization signal or import mechanism identified for SEC23B","No systematic cargo profiling comparing SEC23B-dependent versus SEC23A-dependent clients","In vivo validation of the ULK1–FBXW5–SEC23B autophagy pathway in animal models is lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,7]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,1,2,6]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[0,1,2,5]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[0,1,7]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[7]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[8,11]},{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[8,11]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[0,1,2,5,6,7,10]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[0,1,2,10]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[7]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[8]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,1,13]}],"complexes":["COPII coat complex"],"partners":["SEC24A","SEC24B","SAR1","FBXW5","ULK1","UBF","UBA52","SEC23A"],"other_free_text":[]},"mechanistic_narrative":"SEC23B is a core component of the COPII vesicle coat that mediates ER-to-Golgi transport of secretory cargo, and its tissue-specific requirement is determined by the relative expression of its functionally interchangeable paralog SEC23A rather than by intrinsic biochemical differences between the two proteins [PMID:30065114, PMID:34818036]. Loss-of-function mutations in SEC23B cause congenital dyserythropoietic anemia type II (CDAII) in humans through impaired glycosylation of erythroid membrane proteins [PMID:19561605, PMID:19621418], whereas in mice SEC23B deficiency primarily disrupts professional secretory tissues—pancreatic acinar cells and salivary glands—triggering ER distension, unfolded protein response activation, and apoptosis [PMID:22745161, PMID:28539403]. Beyond canonical COPII trafficking, SEC23B is stabilized during starvation by ULK1-mediated phosphorylation at Ser186, which prevents FBXW5-directed proteasomal degradation and enables a SEC23B–SEC24A/B complex at the ERGIC to promote autophagosome biogenesis [PMID:30596474]; SEC23B also localizes to the nucleus and nucleolus, where it interacts with UBF at rDNA promoters and with EIF2-signaling and ubiquitination pathway components, indicating COPII-independent roles in ribosome biogenesis and ER stress responses [PMID:29893852, PMID:33753724]."},"prefetch_data":{"uniprot":{"accession":"Q15437","full_name":"Protein transport protein Sec23B","aliases":["SEC23-related protein B"],"length_aa":767,"mass_kda":86.5,"function":"Component of the coat protein complex II (COPII) which promotes the formation of transport vesicles from the endoplasmic reticulum (ER). The coat has two main functions, the physical deformation of the endoplasmic reticulum membrane into vesicles and the selection of cargo molecules for their transport to the Golgi complex","subcellular_location":"Cytoplasmic vesicle, COPII-coated vesicle membrane; Endoplasmic reticulum membrane; Cytoplasm, cytosol","url":"https://www.uniprot.org/uniprotkb/Q15437/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SEC23B","classification":"Not Classified","n_dependent_lines":34,"n_total_lines":1208,"dependency_fraction":0.028145695364238412},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000101310","cell_line_id":"CID000895","localizations":[{"compartment":"vesicles","grade":3},{"compartment":"golgi","grade":2},{"compartment":"cytoplasmic","grade":1}],"interactors":[{"gene":"SEC24A","stoichiometry":10.0},{"gene":"SEC24B","stoichiometry":10.0},{"gene":"CLTA","stoichiometry":0.2},{"gene":"DDOST","stoichiometry":0.2},{"gene":"OST4","stoichiometry":0.2},{"gene":"SEC24C","stoichiometry":0.2},{"gene":"SEC24D","stoichiometry":0.2},{"gene":"STT3B","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000895","total_profiled":1310},"omim":[{"mim_id":"621301","title":"PROLINE-RICH COILED-COIL PROTEIN 1; PRRC1","url":"https://www.omim.org/entry/621301"},{"mim_id":"616858","title":"COWDEN SYNDROME 7; CWS7","url":"https://www.omim.org/entry/616858"},{"mim_id":"610512","title":"SEC23 HOMOLOG B, COAT COMPLEX II COMPONENT; SEC23B","url":"https://www.omim.org/entry/610512"},{"mim_id":"610511","title":"SEC23 HOMOLOG A, COAT COMPLEX II COMPONENT; SEC23A","url":"https://www.omim.org/entry/610511"},{"mim_id":"607812","title":"CRANIOLENTICULOSUTURAL DYSPLASIA; CLSD","url":"https://www.omim.org/entry/607812"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Endoplasmic reticulum","reliability":"Supported"},{"location":"Vesicles","reliability":"Supported"},{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/SEC23B"},"hgnc":{"alias_symbol":["CDA-II","CDAII","HEMPAS"],"prev_symbol":["CDAN2"]},"alphafold":{"accession":"Q15437","domains":[{"cath_id":"2.60.40.1670","chopping":"3-53_115-120_400-516","consensus_level":"high","plddt":93.9891,"start":3,"end":516},{"cath_id":"3.40.50.410","chopping":"130-206_228-390","consensus_level":"high","plddt":95.9585,"start":130,"end":390},{"cath_id":"1.20.120.730","chopping":"520-606_730-767","consensus_level":"medium","plddt":88.2602,"start":520,"end":767},{"cath_id":"3.40.20.10","chopping":"623-724","consensus_level":"medium","plddt":95.1439,"start":623,"end":724}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15437","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q15437-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q15437-F1-predicted_aligned_error_v6.png","plddt_mean":92.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SEC23B","jax_strain_url":"https://www.jax.org/strain/search?query=SEC23B"},"sequence":{"accession":"Q15437","fasta_url":"https://rest.uniprot.org/uniprotkb/Q15437.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q15437/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15437"}},"corpus_meta":[{"pmid":"19561605","id":"PMC_19561605","title":"Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II.","date":"2009","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19561605","citation_count":220,"is_preprint":false},{"pmid":"19621418","id":"PMC_19621418","title":"Congenital dyserythropoietic anemia type II (CDAII) is caused by mutations in the SEC23B gene.","date":"2009","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/19621418","citation_count":137,"is_preprint":false},{"pmid":"30596474","id":"PMC_30596474","title":"The ULK1-FBXW5-SEC23B nexus controls autophagy.","date":"2018","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/30596474","citation_count":71,"is_preprint":false},{"pmid":"7607254","id":"PMC_7607254","title":"Carbohydrate-deficient glycoprotein syndrome type II. An autosomal recessive N-acetylglucosaminyltransferase II deficiency different from typical hereditary erythroblastic multinuclearity, with a positive acidified-serum lysis test (HEMPAS).","date":"1995","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7607254","citation_count":69,"is_preprint":false},{"pmid":"869997","id":"PMC_869997","title":"Congenital dyserythropoietic anaemia, types I and II: aberrant pattern of erythrocyte membrane proteins in CDA II, as revealed by two-dimensional polyacrylamide gel electrophoresis.","date":"1977","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/869997","citation_count":69,"is_preprint":false},{"pmid":"22745161","id":"PMC_22745161","title":"SEC23B is required for the maintenance of murine professional secretory tissues.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22745161","citation_count":68,"is_preprint":false},{"pmid":"30065114","id":"PMC_30065114","title":"Functions of the COPII gene paralogs SEC23A and SEC23B are interchangeable in vivo.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30065114","citation_count":63,"is_preprint":false},{"pmid":"27984115","id":"PMC_27984115","title":"Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1.","date":"2016","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/27984115","citation_count":58,"is_preprint":false},{"pmid":"26522472","id":"PMC_26522472","title":"Germline Heterozygous Variants in SEC23B Are Associated with Cowden Syndrome and Enriched in Apparently Sporadic Thyroid Cancer.","date":"2015","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26522472","citation_count":57,"is_preprint":false},{"pmid":"6538436","id":"PMC_6538436","title":"Defect in glycosylation of erythrocyte membrane proteins in congenital dyserythropoietic anaemia type II (HEMPAS).","date":"1984","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/6538436","citation_count":55,"is_preprint":false},{"pmid":"20015893","id":"PMC_20015893","title":"Molecular analysis of 42 patients with congenital dyserythropoietic anemia type II: new mutations in the SEC23B gene and a search for a genotype-phenotype relationship.","date":"2009","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/20015893","citation_count":50,"is_preprint":false},{"pmid":"2136385","id":"PMC_2136385","title":"HEMPAS disease: genetic defect of glycosylation.","date":"1990","source":"Glycobiology","url":"https://pubmed.ncbi.nlm.nih.gov/2136385","citation_count":46,"is_preprint":false},{"pmid":"25071156","id":"PMC_25071156","title":"Absence of a red blood cell phenotype in mice with hematopoietic deficiency of SEC23B.","date":"2014","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25071156","citation_count":43,"is_preprint":false},{"pmid":"9354691","id":"PMC_9354691","title":"Exclusion of three candidate genes as determinants of congenital dyserythropoietic anemia type II (CDA-II).","date":"1997","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9354691","citation_count":42,"is_preprint":false},{"pmid":"6615729","id":"PMC_6615729","title":"Incomplete glycosylation of erythrocyte membrane proteins in congenital dyserythropoietic anaemia type II (CDA II).","date":"1983","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/6615729","citation_count":42,"is_preprint":false},{"pmid":"8043936","id":"PMC_8043936","title":"Congenital dyserythropoietic anaemia type II (HEMPAS) and its molecular basis.","date":"1993","source":"Bailliere's clinical haematology","url":"https://pubmed.ncbi.nlm.nih.gov/8043936","citation_count":40,"is_preprint":false},{"pmid":"1482662","id":"PMC_1482662","title":"Incompletely processed N-glycans of serum glycoproteins in congenital dyserythropoietic anaemia type II (HEMPAS).","date":"1992","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/1482662","citation_count":39,"is_preprint":false},{"pmid":"20941788","id":"PMC_20941788","title":"Mutational spectrum in congenital dyserythropoietic anemia type II: identification of 19 novel variants in SEC23B gene.","date":"2010","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/20941788","citation_count":35,"is_preprint":false},{"pmid":"3020093","id":"PMC_3020093","title":"Parvovirus infection associated with aplastic crisis in a patient with HEMPAS.","date":"1986","source":"Journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/3020093","citation_count":34,"is_preprint":false},{"pmid":"23453696","id":"PMC_23453696","title":"Hypomorphic mutations of SEC23B gene account for mild phenotypes of congenital dyserythropoietic anemia type II.","date":"2013","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/23453696","citation_count":32,"is_preprint":false},{"pmid":"10571015","id":"PMC_10571015","title":"HEMPAS. Hereditary erythroblastic multinuclearity with positive acidified serum lysis test.","date":"1999","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/10571015","citation_count":27,"is_preprint":false},{"pmid":"10753261","id":"PMC_10753261","title":"Gilbert's syndrome accounts for the phenotypic variability of congenital dyserythropoietic anemia type II (CDA-II).","date":"2000","source":"The Journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/10753261","citation_count":24,"is_preprint":false},{"pmid":"1201221","id":"PMC_1201221","title":"The abnormal surface characteristics of the red blood cell membrane in congenital dyserythropoietic anaemia type II (HEMPAS).","date":"1975","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/1201221","citation_count":24,"is_preprint":false},{"pmid":"32017353","id":"PMC_32017353","title":"Hepatitis B subviral envelope particles use the COPII machinery for intracellular transport via selective exploitation of Sec24A and Sec23B.","date":"2020","source":"Cellular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/32017353","citation_count":22,"is_preprint":false},{"pmid":"28539403","id":"PMC_28539403","title":"SEC23B is required for pancreatic acinar cell function in adult mice.","date":"2017","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/28539403","citation_count":21,"is_preprint":false},{"pmid":"27471141","id":"PMC_27471141","title":"Analysis of a cohort of 101 CDAII patients: description of 24 new molecular variants and genotype-phenotype correlations.","date":"2016","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/27471141","citation_count":21,"is_preprint":false},{"pmid":"21850656","id":"PMC_21850656","title":"Two founder mutations in the SEC23B gene account for the relatively high frequency of CDA II in the Italian population.","date":"2011","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/21850656","citation_count":21,"is_preprint":false},{"pmid":"20381388","id":"PMC_20381388","title":"CDAII presenting as hydrops foetalis: molecular characterization of two cases.","date":"2010","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/20381388","citation_count":21,"is_preprint":false},{"pmid":"27297878","id":"PMC_27297878","title":"Pancreatic SEC23B deficiency is sufficient to explain the perinatal lethality of germline SEC23B deficiency in mice.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27297878","citation_count":20,"is_preprint":false},{"pmid":"7506081","id":"PMC_7506081","title":"Aberrant regulation of complement by the erythrocytes of hereditary erythroblastic multinuclearity with a positive acidified serum lysis test (HEMPAS).","date":"1994","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/7506081","citation_count":19,"is_preprint":false},{"pmid":"1141728","id":"PMC_1141728","title":"Abnormal lipid composition of the red cell membrane in congenital dyserythropoietic anemia type II (HEMPAS).","date":"1975","source":"The Journal of laboratory and clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/1141728","citation_count":19,"is_preprint":false},{"pmid":"3663523","id":"PMC_3663523","title":"Congenital dyserythropoietic anaemia type II (HEMPAS): characterization of aberrant intracellular organelles by immunogold electron microscopy.","date":"1987","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/3663523","citation_count":19,"is_preprint":false},{"pmid":"18166993","id":"PMC_18166993","title":"Characterization of the N-glycosylation phenotype of erythrocyte membrane proteins in congenital dyserythropoietic anemia type II (CDA II/HEMPAS).","date":"2007","source":"Glycoconjugate journal","url":"https://pubmed.ncbi.nlm.nih.gov/18166993","citation_count":19,"is_preprint":false},{"pmid":"22208203","id":"PMC_22208203","title":"Congenital dyserythropoietic anemia type II: molecular analysis and expression of the SEC23B gene.","date":"2011","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/22208203","citation_count":18,"is_preprint":false},{"pmid":"7055536","id":"PMC_7055536","title":"Erythrocyte membrane proteins in an unusual case of congenital dyserythropoietic anaemia type II (CDA II).","date":"1982","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/7055536","citation_count":18,"is_preprint":false},{"pmid":"19150496","id":"PMC_19150496","title":"Congenital dyserythropoietic anemia type II (CDAII/HEMPAS): where are we now?","date":"2008","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/19150496","citation_count":17,"is_preprint":false},{"pmid":"3620357","id":"PMC_3620357","title":"Glycolipids and glycopeptides of red cell membranes in congenital dyserythropoietic anaemia type II (CDA II).","date":"1987","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/3620357","citation_count":17,"is_preprint":false},{"pmid":"10800161","id":"PMC_10800161","title":"Geographic distribution of CDA-II: did a founder effect operate in Southern Italy?","date":"2000","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/10800161","citation_count":15,"is_preprint":false},{"pmid":"21252497","id":"PMC_21252497","title":"E109K is a SEC23B founder mutation among Israeli Moroccan Jewish patients with congenital dyserythropoietic anemia type II.","date":"2011","source":"Acta haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/21252497","citation_count":15,"is_preprint":false},{"pmid":"16229933","id":"PMC_16229933","title":"Inhibitory effect of CDA-II, a urinary preparation, on aflatoxin B(1)-induced oxidative stress and DNA damage in primary cultured rat hepatocytes.","date":"2005","source":"Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association","url":"https://pubmed.ncbi.nlm.nih.gov/16229933","citation_count":15,"is_preprint":false},{"pmid":"34818036","id":"PMC_34818036","title":"SEC23A rescues SEC23B-deficient congenital dyserythropoietic anemia type II.","date":"2021","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/34818036","citation_count":14,"is_preprint":false},{"pmid":"10353717","id":"PMC_10353717","title":"Structural and functional consequences of an N-glycosylation mutation (HEMPAS) affecting human erythrocyte membrane glycoproteins.","date":"1998","source":"Biochemistry and cell biology = Biochimie et biologie cellulaire","url":"https://pubmed.ncbi.nlm.nih.gov/10353717","citation_count":12,"is_preprint":false},{"pmid":"11422224","id":"PMC_11422224","title":"Flow-cytometric analysis of erythrocytes and reticulocytes in congenital dyserythropoietic anaemia type II (CDA II): value in differential diagnosis with hereditary spherocytosis.","date":"2001","source":"Clinical and laboratory haematology","url":"https://pubmed.ncbi.nlm.nih.gov/11422224","citation_count":12,"is_preprint":false},{"pmid":"29031773","id":"PMC_29031773","title":"Identification of CDAN1, C15ORF41 and SEC23B mutations in Chinese patients affected by congenital dyserythropoietic anemia.","date":"2017","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/29031773","citation_count":11,"is_preprint":false},{"pmid":"32123160","id":"PMC_32123160","title":"Mutations in the coat complex II component SEC23B promote colorectal cancer metastasis.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/32123160","citation_count":10,"is_preprint":false},{"pmid":"22627135","id":"PMC_22627135","title":"DNA methyltransferase inhibitor CDA-II inhibits myogenic differentiation.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22627135","citation_count":10,"is_preprint":false},{"pmid":"11836161","id":"PMC_11836161","title":"Heterozygosity of CDAN II (HEMPAS) gene may be detected by the analysis of erythrocyte membrane glycoconjugates from healthy carriers.","date":"2002","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/11836161","citation_count":9,"is_preprint":false},{"pmid":"35163229","id":"PMC_35163229","title":"SEC23B Loss-of-Function Suppresses Hepcidin Expression by Impairing Glycosylation Pathway in Human Hepatic Cells.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35163229","citation_count":8,"is_preprint":false},{"pmid":"18761050","id":"PMC_18761050","title":"CDA-II, a urinary preparation, induces growth arrest and apoptosis of human leukemia cells through inactivation of nuclear factor-kappaB in a caspase-dependent manner.","date":"2008","source":"Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association","url":"https://pubmed.ncbi.nlm.nih.gov/18761050","citation_count":8,"is_preprint":false},{"pmid":"29846281","id":"PMC_29846281","title":"Identification of a Novel Mutation in the SEC23B Gene Associated With Congenital Dyserythropoietic Anemia Type II Through the Use of Next-generation Sequencing Panel in an Undiagnosed Case of Nonimmune Hereditary Hemolytic Anemia.","date":"2018","source":"Journal of pediatric hematology/oncology","url":"https://pubmed.ncbi.nlm.nih.gov/29846281","citation_count":8,"is_preprint":false},{"pmid":"29893852","id":"PMC_29893852","title":"Non-canonical role of cancer-associated mutant SEC23B in the ribosome biogenesis pathway.","date":"2018","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29893852","citation_count":7,"is_preprint":false},{"pmid":"37373084","id":"PMC_37373084","title":"New Cases and Mutations in SEC23B Gene Causing Congenital Dyserythropoietic Anemia Type II.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37373084","citation_count":7,"is_preprint":false},{"pmid":"14501626","id":"PMC_14501626","title":"Congenital dyserythropoietic anaemia type II (HEMPAS) and haemochromatosis: a report of two cases.","date":"2003","source":"European journal of gastroenterology & hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/14501626","citation_count":7,"is_preprint":false},{"pmid":"18853186","id":"PMC_18853186","title":"Comparative proteomics and molecular mechanical analysis in CDA-II induced therapy of LCI-D20 hepatocellular carcinoma model.","date":"2008","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/18853186","citation_count":6,"is_preprint":false},{"pmid":"12943172","id":"PMC_12943172","title":"Effect of CDA-II on cell viability, lipid peroxidation, glutathione concentration and its related enzyme activities in primary rat hepatocytes.","date":"2003","source":"The American journal of Chinese medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12943172","citation_count":6,"is_preprint":false},{"pmid":"7066202","id":"PMC_7066202","title":"Congenital dyserythropoietic anaemia type II (CDA-II): chromosomal banding studies and adherent cell effects on erythroid colony (CFU-E) and burst (BFU-E) formation.","date":"1982","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/7066202","citation_count":6,"is_preprint":false},{"pmid":"33753724","id":"PMC_33753724","title":"Non-canonical role of wild-type SEC23B in the cellular stress response pathway.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33753724","citation_count":5,"is_preprint":false},{"pmid":"10519996","id":"PMC_10519996","title":"Suppression of CDA II expression in a homozygote.","date":"1999","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/10519996","citation_count":5,"is_preprint":false},{"pmid":"7734852","id":"PMC_7734852","title":"Polylactosamines are not obligate receptors for invasion of Plasmodium falciparum malaria as shown in HEMPAS variant II-gal- erythrocytes.","date":"1994","source":"Glycobiology","url":"https://pubmed.ncbi.nlm.nih.gov/7734852","citation_count":5,"is_preprint":false},{"pmid":"24801240","id":"PMC_24801240","title":"Congenital dyserythropoietic anemia, type II with SEC23B exon 12 c.1385 A → G mutation, and pseudo-Gaucher cells in two siblings.","date":"2014","source":"Hematology (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/24801240","citation_count":5,"is_preprint":false},{"pmid":"788106","id":"PMC_788106","title":"[Polyagglutinability due to Hempas antigen].","date":"1976","source":"Revue francaise de transfusion et immuno-hematologie","url":"https://pubmed.ncbi.nlm.nih.gov/788106","citation_count":4,"is_preprint":false},{"pmid":"11891809","id":"PMC_11891809","title":"Piebaldism associated with congenital dyserythropoietic anemia type II (HEMPAS).","date":"2002","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/11891809","citation_count":4,"is_preprint":false},{"pmid":"34954140","id":"PMC_34954140","title":"A common human missense mutation of vesicle coat protein SEC23B leads to growth restriction and chronic pancreatitis in mice.","date":"2021","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34954140","citation_count":4,"is_preprint":false},{"pmid":"7959373","id":"PMC_7959373","title":"Hairy cell leukemia associated with congenital dyserythropoietic anemia type II (HEMPAS).","date":"1994","source":"Haematologia","url":"https://pubmed.ncbi.nlm.nih.gov/7959373","citation_count":4,"is_preprint":false},{"pmid":"7451666","id":"PMC_7451666","title":"Congenital dyserythropoietic anaemia type II (HEMPAS): a family study.","date":"1980","source":"Journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/7451666","citation_count":4,"is_preprint":false},{"pmid":"15151542","id":"PMC_15151542","title":"Ineffective erythropoiesis underlies the clinical heterogeneity of congenital dyserythropoietic anemia type II (CDA II).","date":"2004","source":"Pediatrics international : official journal of the Japan Pediatric Society","url":"https://pubmed.ncbi.nlm.nih.gov/15151542","citation_count":3,"is_preprint":false},{"pmid":"6162730","id":"PMC_6162730","title":"Congenital dyserytropoietic anaemia, type II (HEMPAS) in three siblings.","date":"1980","source":"Folia haematologica (Leipzig, Germany : 1928)","url":"https://pubmed.ncbi.nlm.nih.gov/6162730","citation_count":3,"is_preprint":false},{"pmid":"29188620","id":"PMC_29188620","title":"[Analysis of genotype and phenotype of SEC23B gene in a family affected with congenital dyserythropoietic anemia type II].","date":"2017","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29188620","citation_count":3,"is_preprint":false},{"pmid":"23978024","id":"PMC_23978024","title":"[Congenital dyserythropoietic anemia type II with novel mutations in SEC23B and HFE2 genes: a Chinese family survey].","date":"2013","source":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi","url":"https://pubmed.ncbi.nlm.nih.gov/23978024","citation_count":2,"is_preprint":false},{"pmid":"15312436","id":"PMC_15312436","title":"[Abnormalities of the erythrocyte membrane ultrastructure and the membrane proteins in a patient with HEMPAS, alpha thalassemia and complicated diabetes].","date":"2004","source":"Zhonghua nei ke za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/15312436","citation_count":2,"is_preprint":false},{"pmid":"38127226","id":"PMC_38127226","title":"Congenital dyserythropoietic anemia type II in a newborn with a novel compound heterozygous mutation in the SEC23B: a case report and review of the literature.","date":"2023","source":"International journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/38127226","citation_count":2,"is_preprint":false},{"pmid":"10711781","id":"PMC_10711781","title":"Reduced deformability of erythrocytes as feature of congenital dyserythropoietic anaemia type II (HEMPAS).","date":"1999","source":"Clinical hemorheology and microcirculation","url":"https://pubmed.ncbi.nlm.nih.gov/10711781","citation_count":2,"is_preprint":false},{"pmid":"35820731","id":"PMC_35820731","title":"SEC23B missense mutation-associated congenital dyserythropoietic anaemia type II in a child: a rare mimic of chronic haemolytic anaemia.","date":"2022","source":"BMJ case reports","url":"https://pubmed.ncbi.nlm.nih.gov/35820731","citation_count":1,"is_preprint":false},{"pmid":"37455305","id":"PMC_37455305","title":"Development of High-Resolution Melting Curve Analysis for rapid detection of SEC23B gene mutation causing Congenital Dyserythropoietic Anemia type II in Indian population.","date":"2023","source":"Italian journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/37455305","citation_count":1,"is_preprint":false},{"pmid":"31104444","id":"PMC_31104444","title":"[New mutation site of SEC23B gene in type Ⅱ congenital erythrocythememia anemia: one case report and literatures review].","date":"2019","source":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi","url":"https://pubmed.ncbi.nlm.nih.gov/31104444","citation_count":1,"is_preprint":false},{"pmid":"34365611","id":"PMC_34365611","title":"[Variant analysis of SEC23B gene in 4 families with congenital dyserythropoietic anemia].","date":"2021","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34365611","citation_count":0,"is_preprint":false},{"pmid":"17940563","id":"PMC_17940563","title":"[In vitro study about the inhibitory effect of CDAII in combination with sodium butyrate on breast cancer cells].","date":"2007","source":"Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17940563","citation_count":0,"is_preprint":false},{"pmid":"33914262","id":"PMC_33914262","title":"Compound heterozygosity for two novel mutations of the SEC23B gene in congenital dyserythropoietic anemia type II.","date":"2021","source":"International journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/33914262","citation_count":0,"is_preprint":false},{"pmid":"41657939","id":"PMC_41657939","title":"Additive effect of multiple genetic variants in SEC23B and PIEZO1 on iron metabolism dyshomeostasis in hereditary anemias.","date":"2026","source":"HemaSphere","url":"https://pubmed.ncbi.nlm.nih.gov/41657939","citation_count":0,"is_preprint":false},{"pmid":"38655690","id":"PMC_38655690","title":"Identification of a novel splice variant in SEC23B gene in a patient with concomitant presence of congenital dyserythropoietic anemia II and Gilbert's syndrome.","date":"2024","source":"Hematology (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/38655690","citation_count":0,"is_preprint":false},{"pmid":"19175987","id":"PMC_19175987","title":"[In vitro study of the effects of CDA-II combined with cAMP on apoptosis induction in retinoic acid resistant acute promyelocytic leukemia cells].","date":"2008","source":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi","url":"https://pubmed.ncbi.nlm.nih.gov/19175987","citation_count":0,"is_preprint":false},{"pmid":"15745056","id":"PMC_15745056","title":"[Congenital dyserythropoietic anemia--type II (CDA-II) in 3 siblings with long-term follow up and iron overload].","date":"2004","source":"Acta medica (Hradec Kralove). Supplementum","url":"https://pubmed.ncbi.nlm.nih.gov/15745056","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.05.15.25327006","title":"High prevalence of deleterious germline variants in cancer risk genes among subjects with young-onset, sporadic pituitary macroadenomas","date":"2025-05-16","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.15.25327006","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":38406,"output_tokens":4542,"usd":0.091674},"stage2":{"model":"claude-opus-4-6","input_tokens":7979,"output_tokens":3648,"usd":0.196642},"total_usd":0.288316,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2009,\n      \"finding\": \"SEC23B is a component of the COPII coat protein complex involved in ER-to-Golgi vesicular transport, and loss-of-function mutations in SEC23B cause congenital dyserythropoietic anemia type II (CDAII). shRNA-mediated suppression of SEC23B expression recapitulates the cytokinesis defect seen in CDAII, and knockdown of zebrafish sec23b leads to aberrant erythrocyte development, demonstrating SEC23B selectivity in erythroid differentiation.\",\n      \"method\": \"shRNA knockdown in human cells, zebrafish sec23b morpholino knockdown, SEC23B gene sequencing in CDAII patients\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (patient genetics, shRNA knockdown phenotype, zebrafish in vivo knockdown), replicated across two independent studies in same year\",\n      \"pmids\": [\"19561605\", \"19621418\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"SEC23B encodes a COPII coat component that functions in ER-to-Golgi trafficking; its loss disturbs endoplasmic reticulum-to-Golgi trafficking, affecting glycosylation pathways and accounting for the hypoglycosylation of red blood cell membrane proteins observed in CDAII.\",\n      \"method\": \"Proteomic-genomic approach matching cytoplasmic proteome of human RBCs with CDAN2 chromosomal locus; SEC23B gene sequencing revealing 12 different mutations\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — proteomic-genomic approach identifying SEC23B as causative gene, corroborated by independent replication\",\n      \"pmids\": [\"19621418\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SEC23B is required for ER exit of highly abundant cargo in professional secretory tissues. SEC23B-deficient mice die perinatally with degeneration of pancreatic acinar cells and salivary glands but not liver; loss of SEC23B causes ER distension, accumulation of proteins in the ER lumen, and activation of the proapoptotic unfolded protein response pathway, demonstrating tissue-specific dependence on SEC23B for ER export.\",\n      \"method\": \"Germline SEC23B knockout mouse; electron microscopy of pancreatic acini; UPR/apoptosis pathway analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO mouse with defined cellular and molecular phenotypes (ER distension, UPR activation, apoptosis), multiple orthogonal readouts\",\n      \"pmids\": [\"22745161\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SEC23B deficiency restricted to the hematopoietic compartment in mice does not produce anemia or other CDAII features, and SEC23B-deficient hematopoietic stem cells show no disadvantage in competitive repopulation assays, indicating that the erythroid-specific requirement for SEC23B in humans is not recapitulated in mice, possibly due to species-specific shifts in SEC23 paralog expression.\",\n      \"method\": \"Conditional hematopoietic-specific SEC23B knockout mice; bone marrow transplantation and competitive repopulation assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean conditional KO with competitive repopulation assay providing rigorous functional readout\",\n      \"pmids\": [\"25071156\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Pancreatic SEC23B deficiency alone is sufficient to explain the perinatal lethality of germline SEC23B-deficient mice, whereas pancreatic SEC23A deficiency does not cause lethality or pancreatic pathology, demonstrating SEC23B-specific (not SEC23A) requirement for murine pancreatic development.\",\n      \"method\": \"Pancreas-specific conditional SEC23B knockout mice; pancreas-specific SEC23A knockout mice; BAC transgene rescue experiments; immunohistochemistry\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic models (tissue-specific KO, transgenic rescue) with defined molecular and cellular phenotypes\",\n      \"pmids\": [\"27297878\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SEC23B is required for normal function of pancreatic acinar cells in adult mice; acinar cell-specific Sec23b deletion results in decreased zymogen granules, ER alterations (vesicular ER to expanded cisternae with intracisternal granules), induction of ER stress, and increased apoptosis leading to pancreatic cell loss.\",\n      \"method\": \"Tamoxifen-inducible, pancreatic acinar cell-specific Sec23b deletion in adult mice; electron microscopy; ER stress and apoptosis markers\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — inducible tissue-specific KO in adult animals with ultrastructural, molecular, and cellular phenotype readouts\",\n      \"pmids\": [\"28539403\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SEC23A and SEC23B have indistinguishable intracellular protein interactomes in human cells, both complement yeast Sec23, and a Sec23a coding sequence knocked into the murine Sec23b locus completely rescues the lethal SEC23B-deficient pancreatic phenotype. The distinct phenotypes of SEC23A/B deficiency across and within species are explained by evolutionary shifts in their transcription programs rather than unique protein functions.\",\n      \"method\": \"Mass spectrometry interactome analysis; yeast complementation assay; zebrafish transgenic rescue; mouse knockin (Sec23a coding sequence into Sec23b locus)\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (MS interactome, yeast complementation, in vivo knockin rescue) in a single study\",\n      \"pmids\": [\"30065114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The F-box protein FBXW5 targets SEC23B for proteasomal degradation, limiting autophagic flux in nutrient-replete conditions. In response to starvation, ULK1 phosphorylates SEC23B on Serine 186, preventing FBXW5 interaction and SEC23B degradation. Phosphorylated, stabilized SEC23B associates selectively with SEC24A and SEC24B (not SEC24C/D) and relocalizes to the ER-Golgi intermediate compartment to promote autophagic flux.\",\n      \"method\": \"Co-immunoprecipitation; mass spectrometry; in vitro kinase assay; site-directed mutagenesis (S186); subcellular fractionation and live imaging; proteasome inhibitor experiments; autophagy flux assays\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstituted kinase assay, mutagenesis, reciprocal Co-IP, and functional flux assays in a single study with multiple orthogonal methods\",\n      \"pmids\": [\"30596474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Cancer-associated mutant SEC23B localizes to nucleoli independent of other COPII proteins, without compromising secretory function. Mutant SEC23B binds to UBF transcription factor with increased UBF binding at the ribosomal DNA promoter, and mutant cells have increased ribosomal protein and translation-related gene expression and enhanced translational capacity in the presence of ER stress, indicating a non-canonical COPII-independent function in ribosome biogenesis.\",\n      \"method\": \"Immunofluorescence/confocal microscopy (nucleolar localization); co-immunoprecipitation (SEC23B-UBF interaction); ChIP (UBF at rDNA promoter); gene expression microarray; translation assays\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP, ChIP, and localization studies from a single lab with multiple methods but limited independent replication\",\n      \"pmids\": [\"29893852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SEC23B selectively interacts with SEC24A (not other SEC24 paralogs) to form a COPII complex that the hepatitis B virus envelope exploits for ER export. The interaction involves the N-terminal half of SEC24A and a di-arginine motif of the HBV S domain, and HBV replication upregulates SEC23B and SEC24A transcription.\",\n      \"method\": \"Yeast-based proteomics; siRNA silencing of SEC23 and SEC24 paralogs; co-immunoprecipitation; secretion assays in HBV-expressing liver cells\",\n      \"journal\": \"Cellular microbiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP and paralog-specific knockdown with functional secretion readout from a single study\",\n      \"pmids\": [\"32017353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SEC23B mutations impair membrane localization of adhesion proteins EPCAM and CD9, attenuating cell adhesion and promoting invasiveness of colorectal cancer cells. Specific SEC23B mutations (premature stop C649T, or transport-impairing missense C1467G, T488C+G791A+G2153A) inhibit protein transport activity and reduce membrane EPCAM and CD9 levels.\",\n      \"method\": \"Whole-exome sequencing; SEC23B deletion/mutation cell lines; flow cytometry for membrane proteins; cell adhesion and invasion assays in vitro and in vivo (mouse)\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — deletion/mutation functional assays with defined cargo (EPCAM, CD9) and invasion phenotype from a single study\",\n      \"pmids\": [\"32123160\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Wild-type SEC23B localizes to the nucleus in addition to the ER/Golgi interface, and to nucleoli under proteasome inhibition, independent of COPII. Mass spectrometry revealed that wild-type SEC23B interacts with nuclear proteins and with proteins in the ER stress, protein ubiquitination, and EIF2 signaling pathways. SEC23B-UBA52 (RPL40) interaction is validated in a genotype-specific manner. SEC23B levels increase in response to ER stress.\",\n      \"method\": \"Immunofluorescence/confocal microscopy; subcellular fractionation; mass spectrometry proteomics; co-immunoprecipitation (SEC23B-UBA52); patient-derived lymphoblastoid cell lines; ER stress induction experiments\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — unbiased MS proteomics validated by Co-IP, with localization studies; single lab, multiple methods\",\n      \"pmids\": [\"33753724\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Expression of the full SEC23A protein from endogenous Sec23b regulatory elements completely rescues the SEC23B-deficient mouse phenotype. Erythroid-specific deletion of all four Sec23 alleles (both Sec23a and Sec23b) causes mid-embryonic lethality with CDAII features, and deletion of three alleles produces milder erythroid defects. In human SEC23B-deficient HUDEP-2 cells, CDAII features upon differentiation are rescued by increased SEC23A expression.\",\n      \"method\": \"Knockin mouse (SEC23A from Sec23b locus); erythroid-specific conditional double KO mice; SEC23B-deficient HUDEP-2 human erythroid cell line; SEC23A overexpression rescue\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple genetic in vivo models plus human cell line rescue; strong mechanistic conclusions with orthogonal approaches\",\n      \"pmids\": [\"34818036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The common human E109K SEC23B mutation leads to decreased SEC23B protein levels and protein mislocalization. In Sec23b hemizygous (Sec23bki/ko) mice, this results in exocrine pancreatic insufficiency with ER stress and apoptosis, chronic pancreatitis, mild anemia, and severe growth restriction with growth hormone insensitivity. Growth restriction is not associated with hepatocyte-specific Sec23b deletion, implicating a non-liver origin (pancreatic inflammation).\",\n      \"method\": \"Knockin mouse (E109K); conditional hepatocyte-specific Sec23b KO; protein localization studies; ER stress and apoptosis markers; GH axis measurements\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — knockin and tissue-specific KO models with defined molecular and endocrine phenotypes, multiple orthogonal readouts\",\n      \"pmids\": [\"34954140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SEC23B loss-of-function in human hepatic cells (HuH7 and HepG2) impairs glycosylation of membrane proteins involved in the BMP/SMAD pathway, reduces BMP6 sensing, and suppresses hepcidin expression, contributing to iron overload in CDAII. SEC23A overexpression rescues hepcidin suppression, demonstrating functional overlap between SEC23 paralogs in human hepatic cells.\",\n      \"method\": \"Stable SEC23B shRNA silencing in HuH7 and HepG2 cell lines; BMP/SMAD pathway analysis; hepcidin assay; glycosylation studies; SEC23A overexpression rescue\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — stable knockdown in two cell lines with pathway analysis and rescue, but single lab\",\n      \"pmids\": [\"35163229\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"A germline heterozygous SEC23B variant (p.Val594Gly) results in ER-stress-mediated cell colony formation, survival, growth, and invasion in a normal thyroid cell line, distinct from the recessive loss-of-function mechanism causing CDAII. This indicates SEC23B has a role in ER stress response pathways relevant to cancer predisposition.\",\n      \"method\": \"Functional characterization of p.Val594Gly variant in normal thyroid cell line (colony formation, growth, invasion assays); whole-exome sequencing of Cowden syndrome family\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — functional cell-based assays in a single study establishing gain-of-function ER stress mechanism for cancer-associated variant\",\n      \"pmids\": [\"26522472\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Hypomorphic SEC23B mutations that reduce gene expression are not associated with severe CDAII clinical presentation; a compensation mechanism mediated by SEC23A is proposed to justify less severe phenotypes when SEC23B expression is reduced but not absent.\",\n      \"method\": \"Molecular analysis of five novel mutations; SEC23B mRNA and protein quantification in patient erythroid precursors; SEC23A expression analysis\",\n      \"journal\": \"Blood cells, molecules & diseases\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — patient molecular analysis with expression quantification; SEC23A compensation proposed but not directly tested by functional experiment\",\n      \"pmids\": [\"23453696\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SEC23B is a core component of the COPII vesicle coat that functions as a GTPase-activating protein for SAR1 and mediates ER-to-Golgi transport of secretory proteins; its loss causes tissue-specific ER stress and UPR-mediated apoptosis in professional secretory tissues (pancreas, salivary gland) and, in humans, disrupts glycosylation of erythroid membrane proteins leading to CDAII; during starvation, ULK1 phosphorylates SEC23B at Ser186 to prevent FBXW5-mediated proteasomal degradation, stabilizing a SEC23B–SEC24A/B complex that relocalizes to the ERGIC to promote autophagosome biogenesis; additionally, SEC23B has non-canonical COPII-independent roles in the nucleus/nucleolus, interacting with UBF at rDNA promoters and with ER stress/EIF2 signaling pathway proteins, and its functional redundancy with SEC23A is determined by species- and tissue-specific differences in paralog expression rather than intrinsic biochemical differences between the two proteins.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SEC23B is a core component of the COPII vesicle coat that mediates ER-to-Golgi transport of secretory cargo, and its tissue-specific requirement is determined by the relative expression of its functionally interchangeable paralog SEC23A rather than by intrinsic biochemical differences between the two proteins [PMID:30065114, PMID:34818036]. Loss-of-function mutations in SEC23B cause congenital dyserythropoietic anemia type II (CDAII) in humans through impaired glycosylation of erythroid membrane proteins [PMID:19561605, PMID:19621418], whereas in mice SEC23B deficiency primarily disrupts professional secretory tissues—pancreatic acinar cells and salivary glands—triggering ER distension, unfolded protein response activation, and apoptosis [PMID:22745161, PMID:28539403]. Beyond canonical COPII trafficking, SEC23B is stabilized during starvation by ULK1-mediated phosphorylation at Ser186, which prevents FBXW5-directed proteasomal degradation and enables a SEC23B–SEC24A/B complex at the ERGIC to promote autophagosome biogenesis [PMID:30596474]; SEC23B also localizes to the nucleus and nucleolus, where it interacts with UBF at rDNA promoters and with EIF2-signaling and ubiquitination pathway components, indicating COPII-independent roles in ribosome biogenesis and ER stress responses [PMID:29893852, PMID:33753724].\",\n  \"teleology\": [\n    {\n      \"year\": 2009,\n      \"claim\": \"Identification of SEC23B as the CDAII gene established that a specific COPII coat paralog is selectively required for normal erythropoiesis and proper glycosylation of red blood cell membrane proteins, answering which trafficking machinery component underlies this congenital anemia.\",\n      \"evidence\": \"Patient sequencing identifying SEC23B mutations, shRNA knockdown recapitulating cytokinesis defects, and zebrafish morpholino knockdown causing aberrant erythrocyte development\",\n      \"pmids\": [\"19561605\", \"19621418\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which SEC23B loss specifically impairs erythroid glycosylation was not resolved\",\n        \"Whether SEC23A could compensate for SEC23B loss in erythroid cells was untested\",\n        \"Cargo selectivity of SEC23B versus SEC23A was unknown\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"The generation of SEC23B knockout mice revealed that SEC23B is essential for ER export in professional secretory tissues (pancreas, salivary gland) but not liver or erythroid cells in this species, establishing that tissue-specific secretory load determines dependence on SEC23B.\",\n      \"evidence\": \"Germline SEC23B knockout mouse with electron microscopy showing ER distension and UPR/apoptosis pathway activation in pancreatic acinar cells\",\n      \"pmids\": [\"22745161\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Why murine erythropoiesis was spared, unlike human CDAII, was unexplained\",\n        \"Whether the lethality mapped specifically to pancreatic loss of SEC23B was untested\",\n        \"The relative contributions of SEC23A expression levels versus intrinsic protein differences remained ambiguous\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Hematopoietic-specific conditional knockout showed that murine blood formation does not require SEC23B, raising the hypothesis that species-specific paralog expression rather than unique protein functions explains the human-mouse phenotypic discrepancy.\",\n      \"evidence\": \"Conditional hematopoietic-specific SEC23B knockout mice with bone marrow transplantation and competitive repopulation assays\",\n      \"pmids\": [\"25071156\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct measurement of SEC23A versus SEC23B expression in murine versus human erythroid progenitors was not provided\",\n        \"Whether forced reduction of SEC23A in murine erythroid cells would recapitulate CDAII was untested\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Tissue-specific knockouts demonstrated that pancreatic SEC23B deficiency alone accounts for perinatal lethality, while SEC23A loss in pancreas does not, pinpointing the organ and paralog responsible for the mouse lethal phenotype.\",\n      \"evidence\": \"Pancreas-specific conditional SEC23B and SEC23A knockout mice with BAC transgene rescue\",\n      \"pmids\": [\"27297878\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the pancreatic phenotype reflects a unique cargo requirement or simply expression dominance of SEC23B was unresolved\",\n        \"Adult pancreatic consequences of SEC23B loss had not yet been examined\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Inducible acinar-specific SEC23B deletion in adult mice confirmed that SEC23B is continuously required for zymogen granule biogenesis and ER homeostasis in the mature pancreas, not only during development.\",\n      \"evidence\": \"Tamoxifen-inducible acinar cell-specific Sec23b deletion in adult mice with electron microscopy and ER stress/apoptosis markers\",\n      \"pmids\": [\"28539403\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Identity of the specific cargo proteins whose trafficking depends on SEC23B in acinar cells was not determined\",\n        \"Whether SEC23A upregulation could partially compensate over longer time frames was unknown\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Comprehensive interactome and genetic rescue experiments proved that SEC23A and SEC23B are biochemically interchangeable—SEC23A expressed from the SEC23B locus fully rescues the knockout—definitively attributing tissue-specific phenotypes to transcriptional regulation rather than unique protein activities.\",\n      \"evidence\": \"Mass spectrometry interactome comparison; yeast complementation; zebrafish transgenic rescue; mouse knockin of Sec23a coding sequence into Sec23b locus\",\n      \"pmids\": [\"30065114\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Cis-regulatory elements governing tissue-specific SEC23B transcription were not mapped\",\n        \"Whether subtle kinetic or affinity differences exist under specific stress conditions was not excluded\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Discovery that ULK1 phosphorylates SEC23B at Ser186 to prevent FBXW5-mediated degradation established a non-canonical role for SEC23B in autophagosome biogenesis at the ERGIC, linking COPII coat components to the autophagy machinery.\",\n      \"evidence\": \"In vitro kinase assay, site-directed mutagenesis of S186, co-immunoprecipitation, subcellular fractionation, and autophagy flux assays\",\n      \"pmids\": [\"30596474\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How the phosphorylated SEC23B–SEC24A/B complex mechanistically promotes autophagosome membrane formation was not determined\",\n        \"Physiological significance of this pathway in vivo (animal models) was not tested\",\n        \"Whether SEC23A is similarly regulated by ULK1/FBXW5 was not addressed\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The finding that cancer-associated mutant SEC23B localizes to nucleoli, binds UBF at rDNA promoters, and enhances translational capacity revealed a COPII-independent function in ribosome biogenesis.\",\n      \"evidence\": \"Confocal microscopy for nucleolar localization; co-immunoprecipitation for SEC23B–UBF interaction; ChIP at rDNA promoter; gene expression microarray and translation assays\",\n      \"pmids\": [\"29893852\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether wild-type SEC23B has the same nucleolar function or this is neomorphic was unclear\",\n        \"Not independently replicated at time of publication\",\n        \"Structural basis for SEC23B–UBF interaction was not determined\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstration that wild-type SEC23B also localizes to the nucleus and interacts with ER stress/EIF2 signaling and ubiquitination pathway proteins extended the non-canonical nuclear role beyond cancer mutants, establishing that nuclear SEC23B function is a normal feature of the protein.\",\n      \"evidence\": \"Subcellular fractionation, confocal microscopy, mass spectrometry proteomics, and co-immunoprecipitation in patient-derived lymphoblastoid cell lines\",\n      \"pmids\": [\"33753724\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Functional consequences of nuclear SEC23B interactions on ER stress signaling were not causally tested\",\n        \"Single-lab study awaiting independent confirmation\",\n        \"How SEC23B translocates to the nucleus (NLS, chaperone-mediated) is unknown\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Genetic proof that SEC23A expressed from the SEC23B locus fully rescues all SEC23B-deficient phenotypes in mice, and that combined erythroid deletion of all four Sec23 alleles produces CDAII-like features, conclusively resolved the paralog redundancy question and demonstrated that total SEC23 dosage determines erythroid phenotype.\",\n      \"evidence\": \"Knockin mouse expressing SEC23A from Sec23b regulatory elements; erythroid-specific double conditional KO; SEC23A overexpression rescue in human HUDEP-2 cells\",\n      \"pmids\": [\"34818036\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Threshold of total SEC23 protein needed for normal erythropoiesis was not quantified\",\n        \"Whether gene therapy increasing SEC23A could treat CDAII patients was not tested\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Modeling the common CDAII E109K mutation in mice revealed that reduced SEC23B protein levels and mislocalization cause exocrine pancreatic insufficiency with chronic pancreatitis and growth hormone insensitivity, connecting SEC23B hypomorphism to systemic endocrine consequences.\",\n      \"evidence\": \"E109K knockin mouse; hepatocyte-specific conditional Sec23b KO; protein localization, ER stress markers, and growth hormone axis measurements\",\n      \"pmids\": [\"34954140\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism of growth hormone insensitivity (pancreatic inflammation versus direct SEC23B effect) was not fully dissected\",\n        \"Whether these pancreatic/endocrine features occur in human CDAII patients is unknown\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"SEC23B loss in hepatic cells impairs glycosylation of BMP/SMAD pathway receptors and suppresses hepcidin expression, providing a molecular explanation for iron overload in CDAII beyond erythroid defects.\",\n      \"evidence\": \"Stable SEC23B shRNA silencing in HuH7 and HepG2 hepatic cell lines with BMP/SMAD pathway and hepcidin assays; SEC23A overexpression rescue\",\n      \"pmids\": [\"35163229\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"In vivo validation of hepatic hepcidin suppression in SEC23B-deficient models was not performed\",\n        \"Contribution of hepatic versus erythroid dysfunction to CDAII iron overload was not quantified\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis for SEC23B's nuclear import and nucleolar functions, the specific cargo repertoire that depends on SEC23B versus SEC23A in different tissues, the in vivo significance of the ULK1–SEC23B autophagy axis, and whether therapeutic SEC23A upregulation can rescue CDAII in patients.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No nuclear localization signal or import mechanism identified for SEC23B\",\n        \"No systematic cargo profiling comparing SEC23B-dependent versus SEC23A-dependent clients\",\n        \"In vivo validation of the ULK1–FBXW5–SEC23B autophagy pathway in animal models is lacking\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 7]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 1, 2, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [0, 1, 2, 5]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [0, 1, 7]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [8, 11]},\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [8, 11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [0, 1, 2, 5, 6, 7, 10]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [0, 1, 2, 10]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 1, 13]}\n    ],\n    \"complexes\": [\n      \"COPII coat complex\"\n    ],\n    \"partners\": [\n      \"SEC24A\",\n      \"SEC24B\",\n      \"SAR1\",\n      \"FBXW5\",\n      \"ULK1\",\n      \"UBF\",\n      \"UBA52\",\n      \"SEC23A\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}